Clinical Trial Update: A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11) [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-principle trial (POST11) is evaluating whether ondansetron can prevent vasovagal syncope. The study is currently recruiting at the University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Syncope
• Vasovagal Syncope

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: University of Calgary | Conditions: Vasovagal Syncope (VVS), Syncope | Phase 2 | Status: RECRUITING